ป้ายกำกับ: clinical

Novotech Receives CRO Leadership Award for Exceeding Customer Expectations

2022-06-23

On: มิถุนายน 23, 2022

CHICAGO, IL, Jun 23, 2022 – (ACN Newswire viContinue Reading

SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.

2022-06-15

On: มิถุนายน 15, 2022

HONG KONG, Jun 15, 2022 – (ACN Newswire via Continue Reading

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China

2022-06-06

On: มิถุนายน 6, 2022

SYDNEY, Jun 6, 2022 – (ACN Newswire via SEAPContinue Reading

CUHK Professor Elaine Chow Receives “2022 Women’s Interprofessional Network of the American Diabetes Association Abstract Award” for Outstanding Research and Care in Diabetes

2022-06-05

On: มิถุนายน 5, 2022

HONG KONG, Jun 5, 2022 – (ACN Newswire via SContinue Reading

Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal, on the Results of the Phase III Research of Dorzagliatin, a First-In-Class Investigational Diabetes Drug of Hua Medicine

2022-05-13

On: พฤษภาคม 13, 2022

SHANGHAI, CHINA, May 13, 2022 – (ACN NewswirContinue Reading

Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials

2022-05-12

On: พฤษภาคม 12, 2022

SYDNEY, May 12, 2022 – (ACN Newswire via SEAContinue Reading

Novotech Acquires US CRO NCGS, Expands Global Expertise

2022-05-05

On: พฤษภาคม 5, 2022

Singapore & Charlotte, NC, May 5, 2022 –Continue Reading

SinoMab Announces IND APPLICATION FOR SN1011 APPROVED BY NMPA

2022-04-20

On: เมษายน 20, 2022

HONG KONG, Apr 20, 2022 – (ACN Newswire via Continue Reading

Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 – Best Contract Research Organization in APAC

2022-04-19

On: เมษายน 19, 2022

ADELAIDE, AUS, Apr 19, 2022 – (ACN Newswire Continue Reading

Avance Clinical Announces New Office Opening in Melbourne

2022-03-31

On: มีนาคม 31, 2022

MELBOURNE, Mar 31, 2022 – (ACN Newswire via Continue Reading

Kindstar Globalgene Announces FY2021 Annual Results, Revenue Increases to RMB930.67 Million

2022-03-25

On: มีนาคม 25, 2022

HONG KONG, Mar 25, 2022 – (ACN Newswire via Continue Reading

Essex Bio-Technology Announces 2021 Financial Results

2022-03-22

On: มีนาคม 22, 2022

HONG KONG, Mar 22, 2022 – (ACN Newswire via Continue Reading

Eisai to Present New Lecanemab Data Exploring Distinct Mechanism of Action and Clinical Outcomes, Disease State (DSE) Symposium, and Other Pipeline Assets at the AD/PD 2022 Annual Meeting

2022-03-11

On: มีนาคม 11, 2022

TOKYO, Mar 11, 2022 – (JCN Newswire via SEAPContinue Reading

Eisai Initiates Submission of Application Data Under the Prior Assessment Consultation System in Japan with the Aim of Obtaining Early Approval for Investigational Anti-Amyloid Beta Protofibril Antibody Lecanemab

2022-03-04

On: มีนาคม 4, 2022

TOKYO, Mar 4, 2022 – (JCN Newswire via SEAPRContinue Reading

Avance Clinical Announces New Office Opening in Sydney

2022-03-02

On: มีนาคม 2, 2022

SYDNEY, Mar 2, 2022 – (ACN Newswire via SEAPContinue Reading

Novotech Recognized as Top 10 CRO in CenterWatch Site Relationship Benchmarking Report

2022-02-09

On: กุมภาพันธ์ 9, 2022

SYDNEY, Feb 9, 2022 – (ACN Newswire via SEAPContinue Reading

SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE

2022-02-07

On: กุมภาพันธ์ 7, 2022

HONG KONG, Feb 7, 2022 – (ACN Newswire via SContinue Reading

Eisai: Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM

2022-01-28

On: มกราคม 28, 2022

Cambridge, MA, Jan 28, 2022 – (JCN Newswire Continue Reading

Eisai’s Anti-amyloid Beta Protofibril Antibody Lecanemab Selected as the Background Therapy for the Tau Nexgen Study

2022-01-19

On: มกราคม 19, 2022

TOKYO, Jan 19, 2022 – (JCN Newswire via SEAPContinue Reading

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

2022-01-18

On: มกราคม 18, 2022

ADELAIDE, AUS, Jan 18, 2022 – (ACN Newswire Continue Reading